A new European report has revealed that some of the main treatments for osteoporosis and calcium deficiency could have a protective effect against Corona Virus In patients who take it.
According to the results of a joint study by Hospital del Marvi Barcelona, Spain, and the Hospital Del Mar Medical Research Institute (IMIM(Spanish), the study indicates that osteoporosis drugs can specifically reduce 30 to 40% in the incidence rate, and the results were published in the journal Aging.
The author of the study explains, “There are indications that allow it to be assumed that some drugs used to treat rheumatic diseases could positively interfere with the natural history of Corona. COVID-19 Either by reducing its incidence or by reducing its progression to more severe conditions. “
Treatments for osteoporosis and preventing corona–
The study analyzed data from more than 2,000 patients suffering from Osteoporosis, arthritis, and fibromyalgia and their relationship to infection COVID-19 Who are being followed up at Hospital Del Mar and in the healthcare area of Mar Health Park.
The study showed that, in the case of some of the main treatments for osteoporosis such as denosumab, zoledronate and calcium, the data indicate a potentially significant reduction in the incidence of koruna COVID-19 In patients who take it; Specifically, between 30 and 40%, according to the first author of the study and a researcher in the Cell Research Group on Inflammation and Cartilage at Hospital Del Mar Emem, “The study indicates that some of these treatments may protect patients from contracting the virus. COVID-19 Although more studies are still needed to do more patients to prove this, he says.
Osteoporosis
In the case of denosumab, it targets a body system that is involved in the balance of the skeletal system, but it also targets the immune system response by activating and differentiating some of its cells, and its inhibition modulates the inflammatory response, which plays a major role in infection with a virus. COVID-19, As can be modified Zoledronate Also the immune response and may stimulate its activity against -CoV-2.
The results also indicate that another popular treatment for these patients, the antidepressant drug duloxetine, may also have a positive effect in reducing the incidence of COVID-19.
In light of these findings, the study’s reference author suggests that these anti-osteoporosis medications are safe and should continue to be administered to patients who take them. The promising results obtained with the use of duloxetine are significant, while at the same time, we are conducting further studies to verify its potential beneficial effects on COVID-19 “.
– .
/i/2003656016.png?resize=150%2C150&ssl=1)
